Skip to main content

MoneyWorks4Me

Eiko Lifesciences informs about disclosure

16 May 2022 Evaluate

Eiko Lifesciences has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra (HUF).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Godrej Industries 1020.90
SRF 2474.10
BASF India 2927.00
Pidilite Inds. 1571.70
Tata Chemicals 605.40
View more..